A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT)
Abstract
Two patients, one with malignant pleural mesothelioma and one with a malignant short spindle cell tumor, received boron neutron capture therapy (BNCT). In each case, the tumors regressed or remained stable in size for 3–6 months following BNCT. No acute or late adverse events higher than grade 2 were observed.
Keywords: Boron neutron capture therapy, Thoracic tumor, Malignant pleura mesothelioma
To access this article, please choose from the options below
PII: S0167-8140(08)00337-X
doi:10.1016/j.radonc.2008.06.009
© 2008 Elsevier Ireland Ltd. All rights reserved.
